Health Care news, Health Care industry, industry News

▮ More

Smiths H1 Pre-tax Profit Down, Backs FY19 View; Plans Demerger Of Smiths Medical

Novartis To Complete Alcon Spin-off On April 9 - Quick Facts

BD Issues Statement On Paclitaxel-Coated Devices

Inovio Pharma's Ebola Vaccine Shows T Cell, Antibody Responses In Phase 1 Study

Biogen, Eisai To Discontinue Phase 3 ENGAGE, EMERGE Trials Of Aducanumab

Reports: CVS Health Launches Sale Of CBD Products In Eight States

CVS Starts To Sell CBD Products In Eight States

Merck To Invest EUR 1 Bln Until 2025 At Darmstadt Site - Quick Facts

Nevro Stock Up On Appointment Of Keith Grossman As CEO; Suspends FY19 Outlook

Canopy Growth, DNA Genetics Extend Partnership; To Expand To Europe

Tilray Shares Rise On Better-than-expected Sales In Q4

Novavax Q4 18 Earnings Conference Call At 4:30 PM ET

3M Realigns To Four Business Segments From Five - Quick Facts

Merck Announces Label Expansion For KEYTRUDA In Canada - Quick Facts

Aerpio Pharma: TIME-2b Study With AKB-9778 Fails To Meet Primary Endpoint

Genesis Healthcare Q4 18 Earnings Conference Call At 8:30 AM ET

Protalix BioTherapeutics Q4 18 Earnings Conference Call At 8:30 AM ET

Novo Nordisk, Teva Settle US Patent Litigation For Victoza - Quick Facts

Aerpio Pharma Says TIME-2b Study Did Not Meet Primary Endpoint

Novo Nordisk Settles US Patent Litigation Case On Victoza With Teva

AstraZeneca: FDA Grants Saracatinib ODD For Idiopathic Pulmonary Fibrosis

EU Approves Roche's MabThera For Rare Autoimmune Disease

PDL BioPharma Q4 18 Earnings Conference Call At 4:30 PM ET

BioLife Solutions To Buy Automated Thawing Device Maker Astero Bio

BD Announces FDA Premarket Approval For Venovo Venous Stent - Quick Facts

Industries >>

Health Care News

Aerpio Pharma Says TIME-2b Study Did Not Meet Primary Endpoint

Novo Nordisk Settles US Patent Litigation Case On Victoza With Teva

AstraZeneca: FDA Grants Saracatinib ODD For Idiopathic Pulmonary Fibrosis

EU Approves Roche's MabThera For Rare Autoimmune Disease